Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | UGT1A1 | P22309 | 1/20 | 0.33 |
| ▸ | SQLE | Q14534 | 3/20 | 0.33 |
| ▸ | BTN3A1 | O00481 | 3/20 | 0.32 |
| ▸ | FNTA | P49354 | 3/20 | 0.32 |
| ▸ | FNTB | P49356 | 3/20 | 0.32 |
| ▸ | LSS | P48449 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8515809 | 0.90 | BTN3A1 (0.36) | ALDH1A1BTN3A1 | |
| SCHEMBL8515808 | 0.90 | BTN3A1 (0.36) | ALDH1A1BTN3A1 | |
| SCHEMBL6883983 | 0.86 | KMT2A (0.50) | KMT2AALOX15MAPTMEN1CYP3A4 | |
| SCHEMBL31236120 | 0.86 | KMT2A (0.50) | KMT2AALOX15MAPTMEN1CYP3A4 | |
| SCHEMBL6883980 | 0.86 | KMT2A (0.50) | KMT2AALOX15MAPTMEN1CYP3A4 | |
| SCHEMBL14959289 | 0.85 | KMT2A (0.35) | KMT2AALOX15MAPTMEN1CYP3A4 | |
| SCHEMBL9421307 | 0.84 | FNTA (0.38) | KMT2AALOX15MAPTALDH1A1BTN3A1 | |
| SCHEMBL6765570 | 0.83 | SQLE (0.44) | KMT2AALOX15MAPTMEN1CYP3A4 | |
| SCHEMBL7072595 | 0.82 | LSS (0.39) | KMT2AALOX15MAPTMEN1CYP3A4 | |
| SCHEMBL9421365 | 0.81 | HPGD (0.41) | KMT2ASQLEBTN3A1FNTAFNTB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9657313-B2 | Isoprene oligomer, polyisoprene, processes for producing these materials, rubber composition, and pneumatic tire | SUMITOMO RUBBER INDUSTRIES, LTD. (JP) | 2017-05-23 | — | — | US | disclosed |
| US-9657313-B2 | Isoprene oligomer, polyisoprene, processes for producing these materials, rubber composition, and pneumatic tire | SUMITOMO RUBBER INDUSTRIES, LTD. (JP) | 2017-05-23 | — | — | US | disclosed |
| US-20160222418-A1 | ISOPRENE OLIGOMER, POLYISOPRENE, PROCESSES FOR PRODUCING THESE MATERIALS, RUBBER COMPOSITION, AND PNEUMATIC TIRE | SUMITOMO RUBBER INDUSTRIES, LTD. (JP) | 2016-08-04 | — | — | US | disclosed |
| US-20160222418-A1 | ISOPRENE OLIGOMER, POLYISOPRENE, PROCESSES FOR PRODUCING THESE MATERIALS, RUBBER COMPOSITION, AND PNEUMATIC TIRE | SUMITOMO RUBBER INDUSTRIES, LTD. (JP) | 2016-08-04 | — | — | US | disclosed |
| US-9371342-B2 | Isoprene oligomer, polyisoprene, processes for producing these materials, rubber composition, and pneumatic tire | SUMITOMO RUBBER INDUSTRIES, LTD. (JP) | 2016-06-21 | — | — | US | disclosed |
| US-9371342-B2 | Isoprene oligomer, polyisoprene, processes for producing these materials, rubber composition, and pneumatic tire | SUMITOMO RUBBER INDUSTRIES, LTD. (JP) | 2016-06-21 | — | — | US | disclosed |
| US-20140171675-A1 | ISOPRENE OLIGOMER, POLYISOPRENE, PROCESSES FOR PRODUCING THESE MATERIALS, RUBBER COMPOSITION, AND PNEUMATIC TIRE | YAMAGATA UNIVERSITY (JP) | 2014-06-19 | — | — | US | disclosed |
| US-20140171675-A1 | ISOPRENE OLIGOMER, POLYISOPRENE, PROCESSES FOR PRODUCING THESE MATERIALS, RUBBER COMPOSITION, AND PNEUMATIC TIRE | YAMAGATA UNIVERSITY (JP) | 2014-06-19 | — | — | US | disclosed |
| EP-1158995-B1 | BIOLOGICALLY ACTIVE COMPOUNDS OF GANODERMA PFEIFFERI DMS 13239 | GANOMYCIN GES FUER BIOMEDIZINI (DE) | 2003-06-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140171675-A1 | ISOPRENE OLIGOMER, POLYISOPRENE, PROCESSES FOR PRODUCING THESE MATERIALS, RUBBER COMPOSITION, AND PNEUMATIC TIRE | RCE1, GGPS1, TELO2 | KMT2A 4466/4885ALOX15 312/4885MAPT 3569/4885 |
| US-20160222418-A1 | ISOPRENE OLIGOMER, POLYISOPRENE, PROCESSES FOR PRODUCING THESE MATERIALS, RUBBER COMPOSITION, AND PNEUMATIC TIRE | RCE1, GGPS1, TELO2 | KMT2A 4466/4885ALOX15 312/4885MAPT 3569/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.